TOPLINE: The use of semaglutide in patients with diabetes was associated with a significantly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION) compared with those taking drugs for diabetes that belong to other classes of medication. METHODOLOGY: Researchers conducted a retrospective cohort study (October 2019 – December 2023) utilizing a global electronic health registry […]
The post Semaglutide Use Linked to Risk for Vision Loss in Diabetes first appeared on News Health.
Author : News Health
Publish date : 2025-03-28 10:03:00
Copyright for syndicated content belongs to the linked Source.